Strategic Advocates LLC Sells 1,337 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Strategic Advocates LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,793 shares of the medical equipment provider’s stock after selling 1,337 shares during the quarter. Intuitive Surgical comprises about 1.4% of Strategic Advocates LLC’s investment portfolio, making the stock its 17th largest holding. Strategic Advocates LLC’s holdings in Intuitive Surgical were worth $4,068,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Sonora Investment Management Group LLC increased its stake in Intuitive Surgical by 9.0% in the fourth quarter. Sonora Investment Management Group LLC now owns 1,025 shares of the medical equipment provider’s stock valued at $535,000 after acquiring an additional 85 shares during the last quarter. Dumont & Blake Investment Advisors LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $206,000. Crews Bank & Trust bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $360,000. OLD National Bancorp IN boosted its stake in Intuitive Surgical by 1.7% in the fourth quarter. OLD National Bancorp IN now owns 4,450 shares of the medical equipment provider’s stock valued at $2,323,000 after buying an additional 74 shares in the last quarter. Finally, DMC Group LLC bought a new position in Intuitive Surgical in the fourth quarter valued at about $283,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 in the last quarter. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $580.18 on Friday. The stock has a market capitalization of $206.65 billion, a P/E ratio of 90.51, a P/E/G ratio of 5.52 and a beta of 1.39. The business has a 50 day simple moving average of $549.32 and a 200 day simple moving average of $507.50. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday. Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday. Bernstein Bank upped their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday. Royal Bank of Canada raised their price objective on Intuitive Surgical from $611.00 to $641.00 in a report on Monday. Finally, Piper Sandler restated an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.